Obesity

Study Shows Low-Calorie Sweeteners Can Improve Weight Loss and Health

Discover the potential benefits of low-calorie sweeteners for weight management and overall health. A new study out of Denmark suggests that substituting sugar for low-calorie sweeteners can improve weight loss, help weight management, and improve mood. Read on to learn more about the findings and implications of this research.

Foods That Contribute to Chronic Inflammation and How to Manage It with Diet

Chronic inflammation can lead to health issues like fatigue, trouble sleeping, and an increased risk of diseases. Diet plays a crucial role in managing inflammation, with certain foods like char-grilled meat, processed meat products, added sugar, refined carbohydrates, vegetable oils, alcohol, artificial trans fats, and excessive consumption of refined and processed foods contributing to its persistence. Choosing anti-inflammatory ingredients and whole, unprocessed foods can help combat inflammation and promote overall health.

Week of Positive News: Progress in Cancer, Eagles in Cities, and Happiest Countries

This week’s positive news includes a 37% drop in cancer mortality rates in the UK, a remarkable story of triumph over brain cancer, improving air quality in Europe, eagles embracing city life, and the revelation of the ‘happiest’ countries.

New Study Suggests Exercise Can Help Avoid Weight Regain After Stopping Weight Loss Drugs

Half of weight loss drug users stop treatment within a year, but a new study suggests exercise may prevent weight regain. GLP-1 receptor agonists like Ozempic can help patients lose 15% of body weight, but side effects lead to discontinuation. University of Copenhagen study found that those who exercised maintained weight loss, while those who didn’t regained 70% of lost weight, mostly in the form of fat.

Middle-Age Obesity Linked to Changes in Brain Neurons, Japanese Study Finds

Recent research from Japan has uncovered a fascinating link between middle-age obesity and changes in brain neuron shape, with potential implications for humans. The study focused on the impact of a protein called melanocortin-4 (MC4R) on obesity in rats, revealing that MC4R accumulates in primary cilia, affecting metabolism and fat-burning ability. The findings offer valuable insights into the complex relationship between neuronal shape and obesity, potentially paving the way for innovative approaches to weight management and metabolic health.

Estrogen’s protective role against fatty liver disease revealed in new study

New research from Karolinska Institutet reveals how estrogen protects against metabolic dysfunction-associated steatotic liver disease (MASLD), a form of fatty liver disease that has surged during the global obesity epidemic. The study sheds light on a potential future treatment for fatty liver disease and liver cancer, offering promising insights into addressing the rising prevalence of MASLD and its associated health risks.

FDA approves Novo Nordisk’s weight loss drug Wegovy for reducing cardiovascular risk

The FDA has approved Novo Nordisk’s weight loss drug, Wegovy, for reducing the risk of serious cardiovascular complications in adults with obesity and heart disease. This could expand insurance coverage for the drug, addressing a major barrier to patient access. Wegovy has been shown to reduce the overall risk of heart attack, stroke, and cardiovascular-related death by 20%, marking a significant milestone in public health for adults with obesity and heart disease.

Scrutiny over Restrictions on Weight-Loss Drugs Reveals Disparities in Obesity Care Coverage

Healthcare organizations and insurers are facing scrutiny over the restrictions placed on weight-loss drugs, shedding light on the disparities in obesity care coverage. The rise of highly effective weight-loss medications has brought attention to the unequal treatment of obesity within health plans, sparking initiatives like the EveryBODY campaign to advocate for comprehensive coverage. The debate surrounding coverage for obesity care has also been influenced by pharmaceutical companies, with some advocating for broader coverage to expand their customer base. Zeke Emanuel, a medical ethicist, highlighted the disparities in obesity care coverage as a reflection of deep-seated societal biases, emphasizing the need for a more equitable approach to obesity care coverage.

Obesity Surpasses Undernutrition as Most Common Form of Malnutrition Worldwide

Obesity has become the most common form of malnutrition, affecting over one billion people globally. The alarming rise in childhood obesity and the significant health risks associated with excess weight are highlighted in a recent study published in The Lancet. The research underscores the global challenge in addressing the escalating obesity crisis, emphasizing the concerning trajectory of this prevalent form of malnutrition.

French Campaign Aims to Combat Fatphobia and Discrimination Against Individuals with Obesity

French Obese National Associations Collective (CNAO) and BETC Paris launch ‘The Weight of Words’ campaign to combat fatphobia and raise awareness about discrimination faced by individuals with obesity. With nearly half of the adult population in France categorized as overweight or obese, the initiative aims to challenge societal perceptions and promote empathy towards individuals with larger bodies.